Edgewise Therapeutics, Inc. (EWTX)
27.82
-0.57
(-2.01%)
USD |
NASDAQ |
Mar 06, 16:00
27.81
-0.01
(-0.04%)
After-Hours: 20:00
Edgewise Therapeutics SG&A Expense (TTM) : 40.02M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Glaukos Corp. | 331.75M |
| Nuvalent, Inc. | 107.34M |
| Neurocrine Biosciences, Inc. | 1.156B |
| Omeros Corp. | 44.20M |
| Agios Pharmaceuticals, Inc. | 180.28M |